Exploring the use of synthetic placebo populations in ALS randomized clinical trials https://www.medrxiv.org/content/10.1101/2022.12.09.22283281
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.